Sunshine may be problem for CME

Share this article:

The proposed rule for the Physician Payment Sunshine Act is a crucial step toward illuminating physician-industry financial ties. But patient advocacy groups and professional medical associations producing CME, though they may not be “covered recipients” under the law, could be impacted, observes Tom Sullivan, president of Rockpointe.

If such groups get a reportable payment from a manufacturer and use any portion of it or transfer of value toward a covered recipient—a physician or teaching hospital—if “the applicable manufacturer is ‘aware' of the covered recipient's identity, the manufacturer is required to report how much your organization or group…paid.”
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"